CLINICAL_TRIALS
trial_result
· 2023-11-07
Clinical Trial Update: Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B [Phase 2]
Summary
Phase 2 trial evaluating nitazoxanide vs placebo in HBeAg-negative chronic hepatitis B completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Romark Laboratories L.C. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2023-11-07